With a combined revenue of $21 trillion and $2.1 trillion in profits, the 2026 Fortune 500 is the definitive list of America's largest companies.

Fortune 500

Almost $20 trillion in revenue—and a record-breaking $1.87 trillion in profits. Introducing the 2025 Fortune 500, the definitive list of the biggest companies in America.

The Fortune 500, in its 70th year in 2024, ranks the biggest U.S. companies by revenue.

The Fortune 500, in its 69th year in 2023, ranks the biggest U.S. companies by revenue.

This year’s Fortune 500 marks the 68th running of the list.

This year’s Fortune 500 marks the 67th running of the list.

The industrial technology company's wide-ranging businesses provide radio frequency technology, visual effects software, security solutions, and more.

This year's Fortune 500 marks the 66th running of the list.

This year's Fortune 500 marks the 65th running of the list.

This year's Fortune 500 marks the 64th running of the list.

This year's Fortune 500 marks the 63rd running of the list.

This year's Fortune 500 marks the 62nd running of the list.

This year's Fortune 500 marks the 61st running of the list. Wal-Mart claims the top spot again. See who made the list.

Key Financials (last Fiscal Year)

Revenues ($M)

Profits ($M)

Assets ($M)

Total Stockholder Equity ($M)

Profit Ratios

Profit as % of Revenues

Profits as % of Assets

Profits as % of Stockholder Equity

Earnings Per Share (last Fiscal Year)

Earnings Per Share ($)

EPS % Change (from prior fiscal year)

EPS % Change (5 year annual rate)

EPS % Change (10 year annual rate)

Total Return

Total Return to Investors (last year)

Total Return to Investors (5 year, annualized)

Total Return to Investors (10 year, annualized)

Roper Technologies was founded in 1890 by George D. Roper and has evolved from a maker of home appliances, pumps, and industrial products into a diversified technology company. Headquartered in Sarasota, Florida, Roper now focuses on software and engineered products across niche markets, including application software, network software, measurement and analytical solutions, and process technologies.

Q2 2026

Q1 2026

Roper Technologies (ROP): Company Profile, Stock Price, News, Rankings

legacy

Roper Technologies

roper technologies

Good morning. The Roper Technologies conference call will now begin. Today's call is being recorded. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing star zero. I would now like to turn the call over to Zack Moxcey, Vice President, Investor Relations. Please go ahead.

Good morning, and thank you all for joining us as we discuss the second quarter financial results for Roper Technologies. Joining me on the call this morning are Neil Hunn, President and Chief Executive Officer, Jason Conley, Executive Vice President and Chief Financial Officer, Brandon Cross, Vice President and Chief Accounting Officer, and Shannon O'Callaghan, Senior Vice President of Finance. Earlier this morning, we issued a press release announcing our financial results. The press release also includes replay information for today's call. We prepared slides to accompany today's call, which are available through the webcast and are also available on our website. Now, if you'll please turn to page two. We begin with our safe harbor statement. During the course of today's call, we will make forward-looking statements which are subject to risks and uncertainties as described on this page, in our press release, and in our SEC filings.

You should listen to today's call in the context of that information. Now please turn to page three. Today, we will discuss our results primarily on an adjusted non-GAAP basis. For the second quarter, the difference between our GAAP results and adjusted results consists of the following items: amortization of acquisition-related intangible assets, financial impacts associated with our minority investment in Indicor, and lastly, cash collected on Outgo's beneficial interest, which is the residual amount owed to Outgo after it sells receivables to a third party and is classified within cash flows from investing activities. Reconciliations can be found in our press release and in the appendix of our presentation on our website. Now, if you please turn to page four, I'll hand the call over to Neil. After our prepared remarks, we will take questions from our telephone participants. Neil?

Thank you, Zack, and thanks to everyone for joining us this morning. You can see our agenda on page four, so let's get right into it. Next slide, please. As we turn to page five, I want to highlight three takeaways for today's call. First, we delivered solid results and are raising our outlook for the year. Second, AI momentum continues to build across the enterprise at an accelerating pace. Third, we continue to execute our capital allocation opportunities with our long-standing discipline. Let me double-click each point. First, second quarter results were solid and ahead of expectations. Total revenue grew 9%, organic revenue grew 5%, EBITDA grew 5%, and free cash flow grew 11%. Importantly, enterprise gross retention remained strong, consistently in the mid-90s. On that foundation, enterprise software bookings remained solid with core bookings up mid-single digit plus on a TTM basis.

At a high level and across the portfolio, Deltek had an encouraging second quarter, but we're not ready to call a turn in the GovCon market. Relative to Neptune, they had better first half performance than originally expected. Finally, at DAT, we're seeing improving freight market conditions for the first time in many years. On the back of this quarter's performance, we're raising our full-year DEPS guidance for the second time this year to a range of $22.15-$22.30. That is up $0.30 at the midpoint and up $0.80 our original guide in January. In addition, we're raising our full-year revenue growth outlook, with total revenue now expected to be north of 8% and organic growth expected to be in the 6% range. Second, we continue to build momentum around AI and the automation of tasks and workflows within our end markets.

During the quarter, our product release cadence accelerated, and I'd like to highlight both the breadth of what we're doing and the vertical market depth of what each of our businesses is delivering on the AI and agentic product front. Since we last spoke, Deltek released agentic capabilities across both its GovCon and private sector solutions, including RFP development and month-end financial close. Vertafore released its AI Velocity platform with six agentic SKUs, which I'll get into more depth into later. Strata released in beta its AI-enabled financial decision intelligence product. Aderant shipped its first generation of agents across collections, billing appeals, talent, and time capture. Procare shipped its first of many agentic features, RoomRunner, which helps daycare operators optimize enrollment strategies. CentralReach deployed its next generation of AI solutions focused on clinical documentation quality and audit readiness.

DAT continued the evolution of its ML-based freight match automation capabilities, including its first proactive AI recommendation engine, which services load opportunities to carriers who would have not otherwise come across them. SoftWriters, iTrade, Foundry, and ConstructConnect rounded out this quarter's AI and agentic product releases. I know this was a long list, but that's precisely the point. We continue to see very positive signals from our businesses and their ability to build and ship agentic features and products. Our right to win is grounded in the same advantages that have always made our vertical software businesses strong: deep domain expertise, embedded customer workflows, unique data assets, high-trust customer relationships, and scale distribution. Product velocity is also increasing within our businesses. Each company develops AI capabilities close to their customers and their workflows, while our AI accelerator team further increases velocity and scales reusable patterns across the portfolio.

This model is working very well. Demand is strong, but these products are interactive, and in many cases, they change how customers do their work, so the pace of adoption is still developing. What is powerful, though, is that these products will improve with use. As adoption expands, the products get better, knowledge graphs compound, and the value to customers increase. That creates a flywheel. More value drives more adoption, more adoption improves the product, and the cycle accelerates. While we're still early in the commercialization curve, we like the progress we're seeing. Third, we continue to execute with the same consistent, disciplined capital allocation approach that has defined Roper for years. During the quarter, we repurchased another 3.6 million shares, and we expect to soon receive proceeds from Indicor's divestment of its instrumentation businesses to AMETEK.

Let me turn the call over to Jason so he can walk you through the details of both of these and our financials and balance sheet position. Jason?

Thanks, Neil, and good morning, everyone. I'll first take you through our second quarter financial performance beginning on slide six. At a high level, this was a solid second quarter. We finished above the high end of our DEPS guidance range, and organic growth was slightly above expectations. Revenue of $2.1 billion was up 9%, with organic growth of 5% and acquisitions contributing three points. Organic recurring revenue across our software segments grew 7% in the quarter, consistent with our Q1 performance. Further, we expect organic recurring revenue growth to inflect higher as we move into the second half. EBITDA was $815 million, with EBITDA margin of 38.6%. Core EBITDA margin was down 70 basis points.

The reduction was mainly driven by lower margins in our TEP segment, given similar dynamics to Q1, which are: we had higher input costs at Neptune and a mix of more reoccurring consumables at NDI and Verathon. As we move into the second half, we expect margin improvement at Neptune and easy comparisons in the segment. Importantly, in the quarter, core margins across our software segments were down a modest 10 basis points, which includes investment in our AI team. Diluted earnings per share of $5.38 was above our guided range of $5.25 to $5.30, and up 10% over prior year. This outperformance was driven by the combination of solid organic growth and additional buyback activity, which generated $0.03 of accretion in the quarter relative to our guidance. Free cash flow was $447 million, up 11% over prior year.

On a trailing 12-month basis, free cash flow is now at $2.6 billion and has compounded at 18% over the past three years or 15% adjusted for Section 174. Growth in free cash flow coupled with share repurchase activity resulted in free cash flow per share growth of 19% in the quarter. If you turn with me to slide seven, I'll walk you through our financial position and capital deployment. We exited the second quarter at 3.4x net debt to EBITDA, up from 3.1x at the end of Q1, reflecting the capital deployed towards share repurchases in the quarter. We finished with $365 million of cash and $2.9 billion drawn on our $3.5 billion revolver. As Neil mentioned, during the quarter, we repurchased $3.6 million of shares for $1.2 billion, at an average price of approximately $341 per share.

That brings our cumulative repurchases to 9 million shares, spending $3.2 billion since this program began. Said differently, we have repurchased over 8% of our shares in eight months, which gets us back to our 2013 share count position. Also, Indicor announced an agreement to sell its instrumentation businesses to AMETEK, which is expected to close in the second half of this year. As a minority holder in Indicor, we expect gross proceeds of approximately $1.4 billion or an estimated $1.2 billion after tax, which further strengthens our balance sheet and deployment capacity. Of note, the flow control businesses remain in the Indicor portfolio and will provide additional liquidity following a competitive sale process, which is not yet factored into our capacity framework. With good visibility into forward free cash flow and the expected Indicor instrumentation proceeds, we retain more than $5 billion of annualized capacity for capital deployment.

We expect M&A activity to break loose later this year and into 2027, plan to prepare our balance sheet to take advantage of these opportunities. That said, we will remain patient and disciplined and deploy capital to the highest risk-adjusted return investments. With that, I'll turn it back over to Neil to discuss segment performance and our outlook. Neil?

Thanks, Jason. As we turn to page nine, let's review our application software segment. Revenue grew 8% in total, with organic revenue growth of 5%, slightly better than our expectations. EBITDA margins were 42.8%, and core margins declined 20 basis points year-over-year. Organic recurring and reoccurring revenue, which represents about 85% of the segment, continued to grow in the mid-single digit plus range, while non-recurring revenue was down low single digits. Looking across the segment, a couple themes spike out. First, our SaaS transitions continued to advance meaningfully. Several of our larger businesses made real progress on ground to cloud conversions and on bringing new cloud-native products to the market. Over time, this should continue to be a positive trend for the segment. Second, as discussed earlier, AI momentum continues to build across the portfolio. Turning to the business highlights.

Aderant was once again excellent in the quarter. The business continues to win in the market, drive accelerating adoption of its cloud offerings, and build momentum with its agentic AI solutions. Deltek was solid in the quarter, driven by strength in its private sector solutions. GovCon was decent, and we saw some encouraging signs. That said, it is still too early to call it a trend. Before upgrading our GovCon outlook, we'd like to see the sales pipeline convert consistently over the next few quarters. We do expect improvement over time, supported by the market tailwinds from the OBBB, but we're not ready to call that inflection just yet. Vertafore delivered another solid quarter with continued ARR growth. More importantly, faster product delivery is turning its AI strategy into tangible customer solutions.

Its agentic AI strategy targets five areas of insurance distribution: digital servicing, smart submissions, accounting automation, producer workflows, and business intelligence. It starts with high-volume, labor-intensive work where customer value is immediate, then expands into more complex, higher-value workflows. Velocity, Vertafore's purpose-built AI platform, enables rapid agent development directly within systems customers already use. Recently launched with six initial agentic SKUs, it establishes the foundation for continued innovation. Vertafore's high right to win comes from applications that define and run their customers' core workflows. Thousands of customer environments are configured around specific data, products, rules, permissions, and processes. This allows agents to operate inside live environments with unique customer-by-customer context to perform real work accurately and securely. Three products demonstrate the strategy's breadth and value. The reconciliation agent ingests carrier statements, matches transactions, and directs employees only to exceptions, reducing up to an hour of work to minutes.

The submission processing agent converts unstructured emails and documents into underwriting-ready data, reducing processing time from roughly an hour to about two minutes. The portal launcher agent converts static PDF applications into digital submission experiences, enabling MGAs to launch new programs dramatically faster and compete more effectively. These are not features that merely make work faster. They automate meaningful portions of the workflow, improving speed and accuracy, increasing capacity, enabling growth without proportional headcount. That deepens Vertafore's customer value and expands its opportunity beyond software spend into the much larger pool of labor spend. Illumia delivered a strong second quarter, with revenue ahead of expectations as it wins share and cross-sells into the combined CBORD and Transact customer base. Strata also performed well, with its AI strategy accelerating faster than anticipated. Procare remains a work in progress.

The team is advancing a broader product strategy, with RoomRunner released, strong early usage, and more innovation in the pipeline. At the same time, Joe and the team are shoring up the core product, go-to-market execution, and implementation capability. Finally, CentralReach continues to execute at a high level, delivering very strong growth and meaningful margin improvement. As a reminder, CentralReach turns organic next quarter, and after one year, the business is ahead of our deal model. As we turn to our outlook for application software, we expect organic growth for the second half of the year to be in the mid-single-digit plus range. Please turn us to page 10. Total revenue in our network software segment grew 12%, Organic revenue grew 4% in the quarter. Organic recurring growth was strong, growing high singles, was offset by weaker reoccurring and non-recurring revenue at MHA and iPipeline.

EBITDA margins were 50.9%, down 370 basis points year-over-year, while core margins improved slightly, up 30 basis points. The gap reflects two dynamics: the acquisition of Subsplash, a faster growth business with a lower but steadily improving margin profile, and our ongoing investment at DAT, particularly Convoy. Turning to the business level highlights. DAT grew nicely in the quarter and continues to execute at high fidelity. We're also seeing encouraging growth in our digital freight marketplace solutions, with increasing adoption and engagement. Broader market indicators are improving as well. Carrier additions have increased steadily throughout the year, spot pricing is strengthening relative to contract rates, carrier rejection rates are rising. We still need to see load volumes improve before becoming fully bullish on the recovery. The 2026 benefit is tracking modestly ahead of our prior expectations, The indicators remain encouraging as we look towards 2027.

ConstructConnect had another solid quarter, with continued growth of its AI-based takeoff solution. The business is expanding AI deeper into pre-construction workflow, helping customers reduce manual effort, move faster through project documents, and improve decision speed. Foundry continued to deliver year-over-year ARR growth with meaningful AI innovation across SmartRoto and Griptape. SmartRoto automates a historically manual part of the visual effects workflow, while Griptape extends Foundry's position in AI orchestration across production and post-production environments. Subsplash delivered another strong quarter with double-digit software growth, even faster payments growth, and meaningful margin expansion. The business also continued to extend AI across its church engagement and giving platform, taking its AI assistant live to all customers. Finally, I joined our SoftWriters team, which provides the core operating system for long-term care pharmacies for a site visit at LI Script Pharmacy.

I spent time understanding LI Script's strategic and operational priorities and where SoftWriters can help accelerate the business. LI Script serves more than 32,000 beds across 150 facilities, so small workflow improvements create significant value. I sat alongside pharmacists processing prescription orders with and without SoftWriters' AI-powered order entry and review solution. Without automation, a new order can require up to 90 seconds of manual entry and review. Our solution reads the prescription, populates information in the existing workflow, and lets the pharmacist focus on validation rather than transcription. Processing time falls to about 18 seconds per order, an 80% reduction. The benefit extends beyond lower labor costs. It gives pharmacists and technicians more capacity for quality assurance, clinical review, answering nurses' questions, supporting customers, and absorbing volume without proportional headcount. That means better patient care, better customer service, and a more scalable path to growth.

Equally important, the automation is delivered in context at the precise point of work with extremely low latency. SoftWriters derive proprietary data, domain-specific models, dense workflow integration, customer trust, and distribution were evident. It showed how our vertical market modes enable differentiated AI that automates meaningful customer work. Order entry is just the beginning of SoftWriters' workflow automation opportunity. Finally, the monetization model is also attractive and in addition to the existing software spend. SoftWriters prices the solution transactionally, directly aligning revenue with orders automated and labor savings delivered. Customers achieve a clear return while SoftWriters participates in the value created with revenue scaling as adoption and transaction volumes grow. Thank you to the LI Script team for hosting me and for the partnership. Now let me turn to our outlook for network software.

We expect organic growth for the second half of the year to increase versus the first half and be in the mid-single digit plus range. Please turn to page 11 and let's review our TEP segment. Total revenue and organic revenues grew 7%. Results were better than anticipated Neptune, NDI, and Verathon. EBITDA margins were 34.5% down 220 basis points year-over-year, reflecting the same dynamics discussed last quarter. Input cost pressure at Neptune, principally bronze ingot inflation, and a mix shift at both NDI and Verathon towards faster-growing consumables, which carry lower gross margins, though notably more durable and reoccurring revenue profiles. Starting with NDI, the business had another very strong quarter, driven by sustained demand for its electromagnetic tracking solutions across cardiac, neurological, and orthopedic applications.

EP remains a compelling multi-year growth opportunity, with procedure volumes increasing, leading OEMs launching new tracking-enabled catheter platforms, and NDI uniquely positioned at the sensor layer. Neptune had an encouraging quarter. Revenue declined modestly year-over-year, but came in ahead of our expectations as strong mechanical meter volumes and continued growth at Muni-Link helped offset the anticipated decline in market unit volumes. Muni-Link also continues to strengthen Neptune's position across the broader meter to cash workflow through its cloud-based utility billing and customer communication capabilities. The metering business remains on track to return to growth in the second half. Verathon delivered solid growth driven by strong demand for B-Flex and GlideScope single-use offerings. We're also encouraged by the launch of the C-Flex single-use cystoscope and B-Flex specimen collection system, which further expands Verathon's single-use portfolio.

I want to recognize the teams at CIVCO, FMI, and IPA for their excellent work in the second quarter. Each team executed well and contributed to the segment's performance. Turning to our TEP outlook, we expect organic growth for the second half of the year to be in the high singles range and be a bit stronger in Q3. With that, please turn us to page 13. On this page, let's walk through our increased full-year revenue and DEPS guidance, as well as our Q3 outlook. For the full year, we're raising adjusted DEPS guidance to a range of $22.15-$22.30. That represents a $0.30 increase in the midpoint from our prior guide and a $0.80 increase from our original guide. We're also increasing our full-year total revenue growth guidance to north of 8%, with organic revenue growth expected to be in the 6% area.

Please note, this guidance outlook excludes any proceeds from Indicor's divestiture of its instrumentation businesses. For the back half of the year, we expect a tax rate in the 21% area. To reiterate a few key assumptions from our segment commentary, there are some encouraging signs of stabilization at Deltek, but not enough yet to change our outlook. DAT's freight market is improving, and we now expect a modest benefit in 2026, with the setup becoming increasingly encouraging for 2027, and Neptune's first half performance was stronger than we modeled contributing to our first half beat. For Q3, we're establishing adjusted DEPS guidance of $5.75-$5.80. Please turn with us to page 14, and we'll open it up for your questions. We'll conclude with the same three points with which we started. First, we delivered solid second quarter results and are raising our outlook for the year.

Retention remains strong, and based on our year-to-date performance, we're raising full-year DEPS guidance for the second time this year. We're also raising our full-year revenue growth outlook, both for total and organic revenue. Second, AI momentum continues to accelerate across the enterprise. Our product release cadence accelerated meaningfully in the quarter, and our businesses are shipping agentic and AI-enabled capabilities into high-value vertical workflows. Though it's still early, and we will continue learning through the back half of the year, the signals are very positive. We have the vertical market knowledge, deeply embedded workflows, unique data advantages, high-trust customer relationships, and scale distribution to win in the AI era. Our capital allocation framework remains unchanged. We'll deploy capital wherever we see the greatest opportunity for durable, long-term cash flow per share compounding, whether through acquisitions or opportunistic share repurchases.

Over the last eight months, that discipline led us to repurchase approximately $3.2 billion of equity, roughly 9 million shares, or a bit more than 8% of shares outstanding, returning our share count to 2013 levels. We're very pleased by that outcome. Looking ahead, we believe M&A is likely to offer the more attractive long-term compounding opportunity, provided assets meet our strategic and risk-adjusted financial criteria. We expect the M&A market to improve over the coming quarters and are cautiously optimistic about deploying $5 billion or more towards acquisitions over the next 12-18 months. Given this expected improvement, with leverage currently around 3.4x, near-term capital deployment will favor de-leveraging over opportunistic buybacks. We expect to de-lever quickly through strong second-half cash flow and the Indicor proceeds, rebuilding capacity to pursue high-quality acquisition candidates.

In closing, the ingredients for accelerating cash flow per share compounding, our most important financial metric, continue to strengthen. Our portfolio is the strongest it has ever been. Organizational velocity is increasing. AI is expanding our addressable markets, and we expect our product innovation to translate into higher growth over time. Our capital deployment capacity and flexibility remain significant differentiators, most importantly, our discipline is unchanged. With that, we'll open up to your questions.

We will now go to our question and answer session. We request that our callers limit their questions to one main question and one follow-up. If you would like to ask a question, you may do so by pressing star, followed by the digit one on your touch-tone telephone. If you are using a speakerphone, please pick up your handset before pressing any keys. To withdraw your question, please press star, then the digit two. Again, we request that callers limit their question to one main question and one follow-up. Your first question comes from Deane Dray with RBC. Your line is now open.

Thank you. Good morning, everyone, congrats on all the AI SKU launches.

Thank you, Deane. Hey, before you answer your question, I just want to jump in and just say a couple of things, if it's okay, to you personally. Congrats on just a great career and also congrats on stepping away from the day-to-day. I've come to know you, we've come to know you for the better part of the last 15 years, lots of conversations, several road shows. I think the thing that I take away the most from that and respect the most is the way you've done your job. You're always fair, objective, principled, including the moments when we didn't see things the same way. That's pretty amazing. Congrats on that. Appreciate you introducing me to a few leaders who become friends that I can call friends now.

Congrats on a great career. Especially congrats on retirement, and I hope you get plenty of time with that family, especially those grandkids.

Oh my gosh. Thank you so much for all those kind words. It's really been my privilege to follow Roper over the years, and yes, going back to the hallowed days of Brian Jellison. I really appreciate all the help, Neil, you and the team have given me and all the insight. I've got a ton of respect for you all, and I wish you continued success.

Thank you so much. All right. Let's get to your question. Congrats.

Geez, I don't know how I pivot to buybacks, I'm going to. Hey, just the idea here, this is now the second quarter of some sizable buybacks, I'd really be interested in hearing how you look at buybacks on a capital allocation versus a CRI, accretive deal equivalent, what that would need to look like. I think the key here is on a risk-adjusted basis, but if you could just share that insight, that'd be great.

That's right. Happy to do it. We always, first of all, look at what we believe will be the best way to compound our cash flow per share over a longer arc, think a five to seven-year period of time. We've always looked at it this way. Until the last eight months, the capital allocation mathematically always favored M&A. When you look at the returns, both a time zero return, a time five return, whether it's a year five EBITDA, or year five ROIC, to M&A. Obviously, with the last 12 months or so, 12-18 months with the current share price level of Roper in the broader software sector, all of a sudden, buybacks became significantly more attractive. Looking forward, we expect the private values to mirror those or come down to the public values.

We're starting to see some very early signs of that. As we all know, public values are ultimately the gravitational force for all private companies. When that happens, the math turns quite interesting, quite accretive, quite more attractive towards M&A versus buyback. We'll always sort of judge those two between what's best for the long-term cash flow per share compounding.

That's really helpful. Could you just expand on the comment about the pipeline? I think the term was breaking loose, just the expectation on deal flow over the near term.

Yeah. I should also say, on the last question, we always look at the buyback of our own stock versus an acquisition with a risk premium. We obviously know ourself better than anything we could know externally, so we have to sort of be compensated through returns on that. We obviously look at that, and we sort of round out that answer. I forgot your second question already.

Oh, the pipeline. Sorry. Yeah. What I would say there is Janet and her team, they always have a lot of dialogue. The dialogue's turned decidedly more constructive over the last couple of months-ish in terms of the sponsors sort of understanding the valuation landscape. They've had three or four years of DPI pressure. Private credit sort of pressure doesn't help their situation with the public values have been here for, like I said, the better part of 9-12 months, sort of a bounce back. Sort of their hope of a bounce back, this near-term bounce back is likely not going to happen. Sponsors just coming to grips, "The new 15 is yesterday's 25" or whatever the quote is from a couple of sponsors that we've talked to privately. A lot of proprietary opportunities right now.

Sponsors saying, "Hey, if we can get a deal done, we'll just do something with you on a one-off basis." I think that's a sign of where we are, both as a preferred buyer, but also from a macro perspective. That sort of informs our view of the pipeline. We'll always be disciplined, we'll always be patient. I wouldn't anticipate there's like a massive breakthrough of the pipeline in the next small number of months, but we want to prepare the balance sheet to be completely ready when that time comes.

I'd also just say in the channel, like from the investment banking community, we're getting a lot of signals there. Those that do market diligence and consultants, their books are filled up right now quite a bit. That's another signal.

Great. Thank you all very much. Appreciate it.

Your next question comes from Terry Tillman with Truist. Your line is now open.

Hey, Neil, Jason, and Zack. Can you all hear me okay? I've had a bad connection. Can you hear me?

On Vertafore, seems like it is very high value. We do a lot of work in insurtech, and I'd love to kind of double-click on it. I think you all said continued ARR growth. How has the growth compared to the overall software organic, which I think was 5% of the quarter? Then on top of that, with these six agents, have you started to size the potential uplift you could see? Then I had a follow-up.

The ARR growth is a little bit higher than the segment. Trending well there.

I can take the agentic opportunity. We've worked with our partners at Bain. Amy and her team have done their own internal work about what the TAM expansion potential is at Vertafore for the agentic work in the five areas that we talked about in the prepared remarks. It's a doubling-ish of the market size. Now, specific to these six agents, it's a distinct minority or smaller portion of that doubling. This is just the beginning. Think of the scaffolding and the architecture of the agentic platform is probably the biggest part of the release here, and then the six SKUs on top, which means the acceleration of SKUs coming from this point forward should accelerate, and we'll sort of develop product and launch product to sort of fully cover that 2x market opportunity. By the way, these are informed guesses.

I don't think anybody really knows the complete TAM expansion, going in and sort of automating some of these tasks and giving our customers that efficiency certainly lets us sort of monetize some of the labor spend.

Yeah. Then the follow-up is kind of a hard question, unfortunately, but it is kind of you said guesses, because I agree it is all guesses for all of us, but this kind of clearing event and the timing of it really to take hold. I know we talked last quarter, Neil, I'd even mentioned maybe is there some sort of like FDE layer that you have to add? You said scaffolding, then the agents. When do you see the light bulb, the switch flipping where, hey, we're going to really run big, large production workloads? Do you think it's the second half this year or just anything on that? Thanks.

Yeah. I think we said last quarter, and we'll repeat this quarter, as an organization, we've just had an amazing set of learnings on how to build these commercial-grade agentic products over the last 12-18 months, and that's just compounding. We had just an amazing CTO, CPO event. This quarter is the largest in-person Roper event we've ever had, a couple hundred people. Our AI center team, Shane and his team did just an expert job of having a dialogue and discourse and training session on how to build production-grade agentic capabilities, not agent toys, but like truly production-grade. That was incredible. We've come up that learning curve, and we'll continue sort of springboarding sort of that knowledge compounding. Now we're also on a commercialization learning curve. How do we price? How do we deploy? How do we drive utilization?

We'll certainly get our teams together across Roper to sort of share those learnings. Ultimately, whether or not we call them forward deployed engineers or not, I don't know, but definitely the customer service implementation resources will spend more time with our customers driving utilization, teaching them, going through change management, their workflows. It's just the rate of adoption across each of our businesses is the large unknown. Will it be material revenue in the second half? It will not be for us this year. There's momentum building unmistakably inside the organization, and we're excited about that.

The next question comes from Brent Thill with Jefferies. Your line is now open.

Good morning. Just on M&A, I think you had mentioned you're hoping to see the thaw in the cold, but I guess what's underpinning the confidence in that? Is that just, hey, it hasn't thawed forever, or you're now seeing signs underneath that we can't see, that you're just giving the signal that things are in the mix? What's different than, "Hey, we hope it thaws?

Yeah, I think it's similar what we attempted to say a little bit ago, which is the conversations we're having with sponsors are now real conversations. They understand the valuation world that we live in. They've come to grips with that reality. I would say the sponsors that are multi-industry sponsors come to grips with that a little bit quicker than ones that are specialized in sectors, in software sector. As Jason said, the consultants who do a lot of the diligence work are quite busy. The conversation we have with the intermediaries, the bankers, their pipelines are quite busy and quite full. It's that that informs us. The signal is there. It's positive, but it's distant. It takes more than a couple minutes to prepare the balance sheet to play offense. That's what we're doing at the moment.

Okay. Sorry, for the first half of the year, what has been the capital you've deployed?

Well, outside the buyback, there are two small bolt-ons. An aggregate sub $50 million.

50, okay. Okay, great. Just real quick, Jason, for Deltek, can you just give us a sense of how things are going, what you're seeing into the second half of the year?

Yeah. Actually had a good second quarter. We had mentioned a large license deal that we had not put in our guidance that they actually executed on. Drove a little bit of outperformance in the segment. Pipelines look really strong. I think what Neil mentioned in his prepared remarks is that we're really waiting for some of those conversions to be more of a trend before we call it. Certainly, the contractors, the appropriations are starting to move into the contractor world. I think you'll see some of the public company earnings releases have been good. We have really good signal that things are going to move in our direction, but we haven't called it yet.

Your next question comes from Joe Giordano with Cowen. Your line is now open.

Hey, can you I know this probably varies a lot business to business, but when we talk about these AI solutions that you're deploying, can you help us think about what the hit rate internally is? When you're drawing these things up on the whiteboard, how many ideas is it taking to generate something that's actually getting into production versus how these businesses operated in a pre-AI world when you're thinking about improvements?

Yeah. I really appreciate that question. The hit rate right now is quite high. If I step back about really what the, if you will, the transformation we're going through on the product side is, our historical approach to software development being the market leader in each one of our 21 software verticals is sort of methodical and lower risk. In the AI world, you want to go at frenetic pace and actually work with a little bit higher risk because the cost to develop is much lower, so the risk of a mistake is much lower. If you really sort of condense the learning over the last two years, that is the learning of the organization. We're moving at just great pace, and the development here has been great.

The learnings have been, you start with putting AI chat in your products. Not a lot of value there you can monetize. Then you sort of do lighter weight agents that have lower entropy. You get into real commercial-grade, differentiated, high-value agentic workflows, which is what now is being released to the market. The customer signal that we get is incredible. I think I put on social, on LinkedIn, when Procare released their first agentic feature. Mind you, it's not monetized in this particular case, the first one. Within four hours of release, I think 20% of the customer base engaged with the feature. Unheard-of engagement in the software landscape that quickly.

Strata, with their financial decision intelligence tool, they hosted a call, and they had more people on the call seeing the demo of this product than when they merged with Syntellis, to give you a sense of the energy in the market. The number of customers in the beta and the early adopter for some of the Vertafore agents, normally they're capped at a dozen or two, and Amy left it uncapped, and there were more than a couple hundred. The early signal is quite high. I'm just trying to give you a couple data points on this. If the hit rate is, if we miss on a few, that's okay because we've added a little bit of that, if you will, risk given the speed in which we're developing.

On the M&A side, as you evaluate these companies, I know the multiples are weird, and we're maybe talking about what multiples should you pay on a trough type result. How willing are you to underwrite inflections in these businesses? Maybe you're willing to pay a headline sticker price that's way higher multiple than we'll normally see from you because you're willing to underwrite something in the business. How confident are you in ability to kind of pick that here in this world?

We've never been the buyer and fixer of an asset, ever.

At least intentionally, right? We think that we're buying winners that have good momentum behind them, and that's what we're focused on. Increasingly, that'll become easier to discern in the AI era because the targets will have AI growth and earnings, AI related growth products, growth and earnings. The concept of a business that has some headwind attached to it, then somehow we can own it and magically improve it, not really what we do, and I don't see us doing that in the future.

Yep. We're going to buy the winners and make them better.

Your next question comes from Clarke Jeffries with Piper Sandler. Your line is now open.

Hello. Thank you for taking the question. I wanted to ask kind of two interrelated questions around the core margin momentum in the business. Just where do we stand on the quarter-to-quarter movement of the input costs or the mix in TEP? I think core margins were down 70%, but with less contribution from software. I think that implies that TEP improved from a core margin perspective, but love to get sort of the background on what you're seeing and what you expect for the second half.

Sure. I'll take that. Yeah, you're right. It's mostly concentrated in TEP. Core margins were down for the enterprise 70 basis points, and TEP was down substantially more than that. It's really the same dynamics that happened in the second quarter are consistent with what happened in the first, which is at Neptune, they had more of a mix of mechanical meters that shipped, and those have carried higher input costs. A big input cost for them is ingot, which ultimately has copper in it. You've seen what's happened with the price of copper and fulfilling data center demand. That will, in the second half, we've got some offset to that on the price side. We'll have some better offset, and we'll also have more static meter shipments in the second half that don't have as much of that input cost.

We just have more mix of reoccurring consumables across our NDI and Verathon business, which we love because that's higher recurring and it's more secular and more predictable, but they do carry a little bit of lower margin. That's really the primary thing that's going on there. That dynamic in the second half just comps a little bit better. If you look at Q2, it's been our high water mark, but it was a little bit lower this quarter. As you roll into the second half, we'll have better comps in the segment.

Perfect. Then just on the other side of it with the, I think you mentioned core margins and software, being down based off the investment in the AI team. Just curious how you expect the investment to play out. I would imagine that it's heavier today in application software versus network software. Do you have insight to when investment might peak? Just any insight on the relative magnitude of investment in AI team, maybe between the segments or the sort of next 12 months.

Yeah, I think you're right. Most of the, I'd say, activity right now is in application, but all the businesses will have some level of interaction with the AI team. I think we're at maybe the halfway point of where we think that investment's going to be in terms of headcount, but probably much higher on spend because we've started at the more senior level, then we'll add some more entry level and more junior folks as we go through. A lot of that is already in our second quarter base and won't be that much incremental as we go forward.

Your next question comes from Brian Peterson with Raymond James. Your line is now open.

Hey, gentlemen, thanks for taking the question. Neil, I know you're addressing a lot of different markets, but I'm curious, in what of those markets do you think you have the earliest appetite or demand from customers for AI solutions? Maybe what verticals do you think will take a little bit longer to kind of test out those solutions before they step in and buy?

Yeah. We spent a fair amount of time thinking about this, and I think I'll maybe try to answer that on two different axes. There's certainly the industry end market, and I don't know per se if you're in insurance versus healthcare, that the mindset is different in those end markets. One more aggressive, one more conservative. I don't think that's really the dynamic. I think the other one is, we can compare and contrast like CentralReach, which is autism therapy and freight matching automation at DAT. We have incredible take rates, adoptions in autism therapy and methodical month-over-month growth rates are quite nice at DAT, but they're not at escape velocity yet. Why is the difference? Our discernment of that is pretty simple, which is in autism therapy, you have something like 800 million therapy hours demanded, 300 million therapy hours supplied.

There's a line outside the door of every clinic for care. To the extent that we can deliver AI solutions to give therapists more time to see patients, they're seeing patients, patient families are getting the services, the clinic's revenues and earnings are going up. Just everything is aligned. In the DAT example, we can automate the manual, the dozen or so phone calls to broker a load into no phone calls and do it for a fraction of the labor cost. There, you're having to do a change management in the workflow about how loads are brokered. There's a human element of that. There's a change management element of that. There's going to be flavors of that in between. For instance, Vertafore probably sits somewhere in the middle in between those two.

I think it's going to be more about just the level of human change more than it is like industry that drives sort of the rate of adoption.

No, that's great color. I know you mentioned some of your conversations with sponsors. Do you have any sense of where they are in terms of their AI investments, if those are really ramping up? How do we think about that investment or margin cadence of the targets you would be looking at, assuming we do see a thawing of activity in the next couple of quarters? Thanks, guys.

Yeah. This is probably unfair for us to characterize all sponsors the same. We'll do it without naming names, but there's a small number of sponsors that when the gun went off a couple of years ago with AI, like us, decided to put all of their energy around AI into playing offense, driving product velocity, driving revenue growth. That was the principal focus.

The vast majority of sponsors, when the gun went off, said, "Oh, my goodness, I've got an opportunity to take a bunch of cost out of my business, and I'll be able to capitalize that." Now they realized, "Oh, boy, I've got to get on the product journey because I can't sell a software business unless it has a viable AI sort of product roadmap in front of it." As a general matter, I think we're ahead on the product side versus the sponsors, but they're catching up. They know they have to do the agentic SKU delivery and show some defensible increase in growth rate to be able to sort of sell a business at a premium price, whatever the definition of premium is going forward. It's a broad landscape, and you can imagine there's different shades of gray across the sponsors on the AI front.

Your next question comes from Daniel Jester with BMO Capital Markets. Your line is now open.

Roper Technologies (ROP) Q2 2026 Earnings Call Transcript

Company Participants